Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Study to Develop a Blood-based Biomarker Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adult Subjects (CLIN12.1) and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury (CLIN12.2)

NCT07455136 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT07455136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07455136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Study to Develop a Blood-based Biomarker Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adult Subjects (CLIN12.1) and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury (CLIN12.2)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Recruiting
Start date
February 9, 2026
Completion date
November 23, 2028
Enrollment
2,000 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury